Biofrontera Return on Equity (ROE) Growth & History (BFRI)
Biofrontera's return on equity was −141.30% for fiscal 2025.
View full Biofrontera company overviewBiofrontera annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −141.30% | +243.68 pp |
| 2024 | 2024-12-31 | −384.98% | −244.55 pp |
| 2023 | 2023-12-31 | −140.43% | −136.79 pp |
| 2022 | 2022-12-31 | −3.63% | +435.76 pp |
| 2021 | 2021-12-31 | −439.39% | — |
Biofrontera quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10.04% | — |
| Q1 2026 | 2026-03-31 | −57.43% | +114.06 pp |
| Q4 2025 | 2025-12-31 | 142.80% | +170.83 pp |
| Q1 2025 | 2025-03-31 | −171.48% | — |
| Q4 2024 | 2024-12-31 | −28.02% | −148.96 pp |
| Q3 2024 | 2024-09-30 | −68.96% | +85.51 pp |
| Q2 2024 | 2024-06-30 | −9.35% | +72.88 pp |
| Q4 2023 | 2023-12-31 | 120.94% | +132.93 pp |
| Q3 2023 | 2023-09-30 | −154.48% | −141.59 pp |
| Q2 2023 | 2023-06-30 | −82.24% | −77.33 pp |
| Q1 2023 | 2023-03-31 | −36.81% | −75.49 pp |
| Q4 2022 | 2022-12-31 | −11.99% | — |
| Q3 2022 | 2022-09-30 | −12.89% | — |
| Q2 2022 | 2022-06-30 | −4.91% | — |
| Q1 2022 | 2022-03-31 | 38.68% | — |
Biofrontera return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Biofrontera's return on equity increased from −439.39% to −141.30%, a change of +298.09 percentage points. The latest reported quarter, Q2 2026, shows −10.04%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera source filings ↗